U.S. and British agencies announced on the 7th, each side has a new coronavirus vaccine research and development is progressing smoothly, is expected to enter the clinical trial phase soon. The new corona vaccine, developed by the National Institutes of Health and biotech company Modena, is expected to enter phase one clinical trial within two and a half months, Said Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases, a unit of the National Institutes of Health.
At a press conference with the U.S. Department of Health, Fauci said researchers obtained data from viral gene sequences published by their Chinese counterparts and successfully injected the gene into Modna’s messenger RITs (mRNA) platform to begin guiding protein synthesis, marking the first step in vaccine development. Next, the researchers will inject these proteins into mice to induce immunogenicity. If all goes well, it will be in phase One clinical trials within two and a half months.
Oxford University announced Wednesday that a team from the university’s Jenner Institute is preparing to conduct clinical trials for a candidate vaccine against a new coronavirus.
According to the university, the “seed reserve” of the candidate vaccine is being produced at a clinical biomanufacturing facility at Oxford University, where it will then be handed over to an Italian manufacturer, which plans to produce 1,000 doses of the vaccine for clinical trials.
Previously, the Middle East Respiratory Syndrome (MERS) vaccine developed by the Jenner Institute has shown good results in the first clinical trial, using one dose to trigger a stronger immune response to the MERS virus. Researchers say they are using the same technical pathways as developing the MERS vaccine to develop a vaccine for the new coronavirus, which could reduce the time it takes to prepare clinical trials for the new vaccine.